Risk mitigation strategies for children and young people admitted with mental health crisis to acute paediatric care: A systematic review with narrative synthesis.

J Child Health CareAug 29, 2025 (epub)
Clinical ResearchPediatricsPsychiatry

Takawira C Marufu, Aikaterina Kaltsa, Zaki Albelbisi et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review with narrative synthesis examined evaluated pathways for managing self-harm and suicidality risk among children and young people admitted to acute hospital settings during a mental health crisis. Searches of eight academic databases through February 2022 identified 120 potential studies; five met the inclusion criteria. The review identified six strategies: safety huddles, urgent psychiatric review within 2 hours of assessment, feedback on screening responses, motivational and barrier-reducing interventions, constant 1:1 observation, and environmental safety measures. Strategies addressed environmental, family, and individual factors through changes to equipment, surveillance, and communication.

Key findings

  • Five studies met the review’s inclusion criteria from 120 potential studies identified.
  • Six risk mitigation strategies were identified, including safety huddles, urgent psychiatric review within 2 hours, and constant 1:1 observation.
  • Strategies targeted environmental, family, and individual factors, using changes to equipment, surveillance, and communication.

Why it matters

Children and young people admitted during mental health crises may experience fluctuating distress and risk of self-harm or suicide. The review maps approaches evaluated in acute paediatric settings and highlights that risk mitigation can involve coordinated attention to the care environment, family, and the young person. This offers a framework for understanding the range of strategies described in the available evidence.

What to keep in mind

Only five studies met the inclusion criteria, limiting the breadth of evidence available to inform conclusions.

Source

Published in J Child Health Care. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pediatrics

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.